- Local governmentsIncreased access to primary and routine care in shortage and underserved areas by enabling beneficiaries to receive cer…
- Potential benefitPotential substitution of pharmacist-provided services for physician visits for eligible services, which could lower pe…
- Local governmentsSupport for community pharmacies and pharmacist employment in underserved areas by creating a new billing pathway and r…
Pharmacy and Medically Underserved Areas Enhancement Act
Read twice and referred to the Committee on Finance.
The bill (Pharmacy and Medically Underserved Areas Enhancement Act) would amend Medicare to recognize and pay for certain pharmacist services when furnished in health professional shortage areas, medically underserved areas, or medically underserved populations. It defines "pharmacist services" as services a pharmacist is licensed and legally authorized to perform under state law, and that would otherwise be covered if provided by a physician or incident to a physician’s service.
Scope and reach: liberals want broader geographic/scope coverage and stronger workforce recognition; conservatives prefer tighter, time-limited, or piloted expansion.
Relative to its intended legislative type, this bill creates a clear and focused substantive change to Medicare coverage and payment by adding pharmacist services for specified underserved settings and defining a payment formula, but it leaves significant operational, fiscal, and oversight details unaddressed.
The bill (Pharmacy and Medically Underserved Areas Enhancement Act) would amend Medicare to recognize and pay for certain pharmacist services when furnished in health professional shortage areas, medically underserved areas, or medically underserved populations.
It defines "pharmacist services" as services a pharmacist is licensed and legally authorized to perform under state law, and that would otherwise be covered if provided by a physician or incident to a physician’s service.
Payment is specified as 80 percent of the lesser of the pharmacist’s actual charge or 85 percent of the physician fee-schedule amount for the same service; the provisions would take effect for services furnished on or after January 1, 2027.
Content‑wise this is a focused, administratively implementable expansion of Medicare coverage aimed at improving access in underserved areas and includes cost‑mitigating design choices. Those features increase its chance relative to large, transformative bills. However, it still creates new Medicare payment obligations and touches on professional scope‑of‑practice issues that can provoke organized opposition, and it would need committee approval and floor time (particularly in the Senate) where procedural and coalition hurdles exist. Overall the bill has plausible bipartisan appeal but meaningful procedural and stakeholder uncertainties lower its standalone likelihood of enactment.
Relative to its intended legislative type, this bill creates a clear and focused substantive change to Medicare coverage and payment by adding pharmacist services for specified underserved settings and defining a payment formula, but it leaves significant operational, fiscal, and oversight details unaddressed.
Scope and reach: liberals want broader geographic/scope coverage and stronger workforce recognition; conservatives prefer tighter, time-limited, or piloted expansion.
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenRisk of increased overall Medicare spending if expanded billing authority leads to higher utilization (more billed enco…
- StatesAdministrative and implementation burdens for CMS and providers, including developing new billing codes, updating claim…
- StatesPotential quality, oversight, and scope-of-practice concerns because allowed pharmacist services are limited by state l…
Why the argument around this bill splits.
Scope and reach: liberals want broader geographic/scope coverage and stronger workforce recognition; conservatives prefer tighter, time-limited, or piloted expansion.
A mainstream liberal would likely view the bill positively for expanding access to primary and preventive care in underserved communities and for recognizing pharmacists as a health workforce resource.
They would welcome Medicare paying pharmacists in shortage and medically underserved areas because it could reduce access gaps and improve chronic disease management.
However, they would note limitations: payment is below physician rates, the provision is limited to designated underserved areas, and the authority of pharmacists to provide services still depends on state scope-of-practice laws.
A pragmatic centrist would probably consider the bill a sensible, targeted measure to expand access where primary care shortages exist while being relatively modest in scope and cost.
They would appreciate the targeting to HPSAs/MUAs and the explicit payment formula that creates predictability, but would be attentive to administrative details, fraud/abuse protections, and fiscal implications.
They would want clearer implementation guidance (coding, interactions with state laws, coordination with physicians) and outcomes evaluation.
A mainstream conservative would be skeptical of expanding federal Medicare coverage to another provider type and of increasing federal payment obligations, even if targeted to shortage areas.
They might accept the bill’s focus on underserved areas as a limited, pragmatic approach, but would be concerned about federal creep into scope-of-practice issues traditionally handled by states and about potential new costs and program complexity.
Conservatives would press for tight limits, strong anti-fraud measures, and possibly a pilot or sunset rather than open-ended expansion.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Content‑wise this is a focused, administratively implementable expansion of Medicare coverage aimed at improving access in underserved areas and includes cost‑mitigating design choices. Those features increase its chance relative to large, transformative bills. However, it still creates new Medicare payment obligations and touches on professional scope‑of‑practice issues that can provoke organized opposition, and it would need committee approval and floor time (particularly in the Senate) where procedural and coalition hurdles exist. Overall the bill has plausible bipartisan appeal but meaningful procedural and stakeholder uncertainties lower its standalone likelihood of enactment.
- No official cost estimate (e.g., CBO) is included in the bill text; total fiscal impact is therefore unknown and could materially affect legislative support.
- The bill ties coverage to services that 'would otherwise be covered under this part if furnished by a physician,' but it does not enumerate which pharmacist actions are expected to be covered—this ambiguity could create disputes during rulemaking or legislative debate.
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Scope and reach: liberals want broader geographic/scope coverage and stronger workforce recognition; conservatives prefer tighter, time-lim…
Content‑wise this is a focused, administratively implementable expansion of Medicare coverage aimed at improving access in underserved area…
Relative to its intended legislative type, this bill creates a clear and focused substantive change to Medicare coverage and payment by adding pharmacist services for specified underserved settings and defining a paymen…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.